• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Elligo Health Research names Rebecca Kush scientific innovation officer

Elligo Health Research names Rebecca Kush scientific innovation officer

May 17, 2017
CenterWatch Staff

Elligo Health Research, a clinical research infrastructure (CRI) provider that brings together sponsors, clinicians, patients and CROs to improve clinical trial access and efficiency, has hired Rebecca Kush, Ph.D., as scientific innovation officer.

Kush is the founder and was the president and CEO of the Clinical Data Interchange Standards Consortium (CDISC) where she spent 20 years leading the development of global clinical research data standards to streamline clinical research. While there, she had an integral role in the development of methods and processes to link research and healthcare.

Kush’s extensive research and process expertise will support Elligo’s unique Goes Direct approach, using electronic health record data to identify patients for research studies, then providing these patients’ physicians with the personnel, procedures, technology and infrastructure necessary to conduct the study in their own clinics.

Kush earned a doctorate in physiology and pharmacology from the University of California, San Diego, School of Medicine and also has worked for the U.S. National Institutes of Health, academia, a global CRO and U.S. and Japanese pharmaceutical companies during her career.

“This anchors an important area of growth for Elligo,” said John Potthoff, Ph.D., co-founder and CEO of Elligo Health Research. “Kush’s unrivaled experience in data standards will have an immediate impact—widening access to data for trial sponsors from source to submission.”

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing